WallStreetZenWallStreetZen

NASDAQ: DVAX
Dynavax Technologies Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Dynavax Technologies earnings were $27.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest DVAX earnings report on Dec 31, 2024 announced Q4 2024 earnings of $7.1M, down 59.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DVAX reported annual earnings of $27.3M, with -527.4% growth. The next DVAX earnings date is May 6, 2025.

DVAX past earnings growth

How has DVAX's earnings growth performed historically?

Company
N/A
Industry
55.42%
Market
65.38%
DVAX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DVAX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

DVAX earnings history

Current Revenue
$277.2M
Current Earnings
$27.3M
Current Profit Margin
9.9%

DVAX Return on Equity

Current Company
4.3%
Current Industry
12.5%
Current Market
34.1%
DVAX's Return on Equity (4.3%)... subscribe to Premium to read more.
High Return on Equity Performance

DVAX undefined

Current Company
2.7%
Current Industry
5.5%
DVAX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DVAX announces earnings.

DVAX undefined

Current Company
4.15%
Current Industry
12%
DVAX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DVAX vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DVAX$45.70M$27.31M-87.12%$0.21
INDV$83.00M$2.00M-57.83%$0.02
EVO-$89.62M-$217.86MN/A-$0.62
ANIP$64.65M-$20.15MN/A-$1.04
PCRX$32.25M-$99.56MN/A-$2.15
View Top Pharmaceutical Stocks

DVAX earnings dates

Next earnings date
May 6, 2025

Dynavax Technologies Earnings Reports & History FAQ

What were Dynavax Technologies's earnings last quarter?

On DVAX's earnings call on Invalid Date, Dynavax Technologies (NASDAQ: DVAX) reported Q4 2024 earnings per share (EPS) of $0.06, up Infinity% year over year. Total DVAX earnings for the quarter were $7.05 million. In the same quarter last year, Dynavax Technologies's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Dynavax Technologies stock.

When does Dynavax Technologies report earnings?

The next DVAX earnings date is Invalid Date. Add DVAX to your watchlist to be reminded of Dynavax Technologies's next earnings date.

Is Dynavax Technologies profitable or losing money?

As of the last Dynavax Technologies earnings report, Dynavax Technologies is currently profitable. Dynavax Technologies's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $27.31 million, a 527.44% decrease year over year.

What was DVAX's earnings growth in the past year?

As of Dynavax Technologies's earnings date in Invalid Date, Dynavax Technologies's earnings has grown year over year. DVAX earnings in the past year totalled $27.31 million.

What are Dynavax Technologies's earnings expectations?

The current EPS estimate for Dynavax Technologies's earnings report in Invalid Date is $0.01.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.